Neal Kevin Dalton

Title: Neal Kevin Dalton: Innovator in Peptidic Compounds

Introduction

Neal Kevin Dalton is a notable inventor based in Caringbah, Australia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of peptidic compounds. With a total of two patents to his name, Dalton's work focuses on innovative solutions for treating bacterial and HIV infections.

Latest Patents

Dalton's latest patents include compounds that are defined by specific formulas (I, II, III, and IV) and their pharmaceutically acceptable derivatives. These compounds are designed for use in the treatment of bacterial infections and HIV infections. Additionally, his patents encompass pharmaceutical compositions that incorporate these innovative compounds, showcasing his commitment to advancing medical treatments.

Career Highlights

Neal Kevin Dalton is affiliated with the University of Wollongong, where he continues to engage in research and development. His work has garnered attention for its potential impact on public health, particularly in combating infectious diseases. Dalton's expertise in peptidic compounds positions him as a key figure in pharmaceutical innovation.

Collaborations

Dalton collaborates with esteemed colleagues such as Timothy Patrick Boyle and Zinka Brkic. These partnerships enhance the research efforts and contribute to the advancement of their shared goals in the field of pharmaceuticals.

Conclusion

Neal Kevin Dalton's contributions to the development of peptidic compounds highlight his role as an innovator in the pharmaceutical industry. His work not only addresses critical health challenges but also exemplifies the importance of collaboration in scientific research.